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PLANT TISSUE COMPRISING A mosaic virus. Although the (+) strand RNA viruses of plants 
SUBGENOMIC PROMOTER and animals are diverse with respect to host range. genome 
and oarticle structures. and exact mechanisms of viral r - -  
~ h i ~  is a division of application ser. N ~ .  08J296.080, replication. there are some amino acid and nuclei~ acid 
filed Aug. 25. 1994, now U.S. Pat. No. 5.466.788. sequence homologies (reviewed in R. Goldbach (1987) Microbiol. Sci. 4:197). Amino acid sequence homologies 
FIELD OF THE INVENTION have been described fbr poliovirus. foot-and-mouth disease 
and cowpea mosaic viruses (H. Franssen et. al. (1984) 
The field of this invention is the area of molecular EMBO J. 32355). and for nonstructural proteins encoded by 
biology. and it relates in particular to the field of (+) strand lo brome mosaic virus, alfalfa mosaic virus. tobacco mosaic 
RNA viruses. The teachings of the Present invention will virus and Sindbis virus (J. Haseloff et al. (1984) Proc. Nat. 
enable the use of a viral control sequence, termed a subge- Acad. Sci. USA 81:4358; P. Ahlquist et al. (1985) J. Virol. 
nomic promoter. for directed gene expression in the 53536). The homologous regions within the nonstructural 
priate cell host. Specificdly. the subgenomic promoter of proteins are believed to reflect mechanistic similarities in the 
RNAz of brome mosaic virus is exemplified to the 15 replication of viral nucleic acid and possibly evolutionary 
expression of a structural gene in plant tissue. relationships. 
BACKGROUND OF THE INVENTION 
Single-stranded RNA viruses which are capable of repli- 
cating in the cytoplasm of host cells are widespread in 
nature. Those single-stranded viruses with message-sense 
genomic RNA molecules are called (+) strand. or positive 
strand. RNA viruses. Among the known (+) strand RNA 
viruses there are bacteria-specific. animal-specific, and 
plant-specific varieties. There is much diversity in the mor- 
phology of virus particles. coat proteins. genetic 
organization, and genome size. The (+) strand RNA viruses 
include. but are not limited to. Q-beta bacteriophage, polio- 
The alphaviruses and the Sindbis-like plant viruses also 
share a common strategy for synthesis of coat protein (and 
in some cases for the synthesis of additional protein(s). That 
zo strategy is the use of an internal promoter to direct the 
synthesis of a (+) strand RNA molecule. called a subge- 
nomic RNA. using the (-) strand as template. The subge- 
nomic RNA comprises a subset of sequences found in the 
comesponding "genomic" (full-length) RNA. and may be 
25 encapsidated in viral particles. In the case of the brome 
mosaic virus (BMV), (+) strand RNA molecules outnumber 
the full-length (-) strand template about 100 to I. and 
subgenomic and full-length genomic W A S  are made in 
virus and alphaviruses (including Sindbis virus) of animal ap@oximately equimolar amounts (French and Ahlquist 
cells. and the bromoviruses (including brome mosaic virus) 30 (1987) J. Virol. 61:1457). The subgenomic mRNA. which in 
and the comoviruses (including cucumber mosaic virus) of BMV carries only the message for coat protein. is very 
plants. effectively translated by the cellular protein synthetic 
A general review of (+) strand virus replication has been machinery. For example. gram quantities of BMV-infected 
published (E. Strauss and J. Strauss (1983) Curr. Top. plant tissue synthesize milligram amounts of coat protein (L. 
Microbiol. Immunol. 105:l). A brief summary of the steps 35 Lane (1981) in Handbook of Plant Mrus Infections and 
follows. Virally determined proteins may be required Comparative Diagnosis, E. Kurstak Ed.. ElsevierNorth- 
together with the genomic RNA(S) for infection to occur, or Holland, Amsterdam pp. 333-376). 
all the viral proteins required to initiate virus replication may The bromoviruses are a group of (+) strand plant viruses 
be synthesized using the incoming viral genomic RNA as with tripartite genomes. Included in this grouping are brome 
message. There is no DNA intermediate in the replication of 40 mosaic virus, cowpea chlorotic mosaic virus (CCMV). and 
the nucleic acid of these viruses; the replication of the broadbean mosaic virus (BBMV). CCMV and BBMV infect 
genetic information of a (+) strand RNA virus requires the the dicots cowpeas and broadbeans respectively. and the host 
RNA-dependent RNA synthetic capability of cells infected range of BMV is the grasses. including the cereals (L. C. 
with such viruses. The incoming genomic (+) strand serves Lane. (1981) in The Handbook of Plant Wrus Infections and 
as template for the synthesis of (-) strand molecules. and 45 Comparative Diagnosis. Chapter 12. Elsevier. Amsterdam). 
then progeny (+) strands are synthesized using the (-) Barley is a common experimental host for BMV. which has 
strands as templates. At the latter step there is an amplifi- been well characterized. 
cation of (+) strands over (-) strand molecules. The (+) BMV strain M1 (Madison 1) (P. Ahlquist et al. (1984) 
strand viral RNA molecule(s) are generally translated. at 
 roc. Nat. Acad. Sci. USA 81:7066) is the experimental 
least in part. to yield virus-specific replicase. The (-) strands 50 
serve as the templates for subsequent synthesis of large 
numbers of (+) strands which may carry structural genes and 
which are destined to become encapsidated by coat protein. 
Structural proteins are translated from genomic RNA or 
from subgenomic RNA, depending on the virus. In the 55 
instance of the (+) strand viruses with multicomponent RNA 
genomes. the RNA molecules may be encapsidated in sepa- 
rate viral particles. in which case the host cell must be 
simultaneously infected with each component to yield a 
productive infection. 60 
The plant (+) strand RNAviruses have been classifiedinto 
two supergroups (R. Goldbach (1986) Ann. Rev. Phyto- 
pathol. 24:289). The picornavirus-like supergroup includes 
comoviruses, nepoviruses. and potyviruses, while the sec- 
ond supergroup includes those viruses which resemble the 65 
animal alphavirus Sindbis virus: the tobamoviruses, 
tobraviruses, bromoviruses. cucumoviruses. and alfalfa 
system chosen to exemplify the present invention.The BMV 
genome is composed of three RNA molecules of unique. 
known sequence: RNAl is 3234 bases in length. RNA2 is 
2865 bases in length (l? Ahlquist et al. (1984) J. Mol. Biol. 
172:369). and RNA3 is about 2114 bases in length (P. 
Ahlquist et al. (1981) 5. Mol. Biol. 15323). Complete cDNA 
clones have been produced (P. Ahlquist and M. Janda (1984) 
Mol. Cell. Biol. 4:2876). RNAs 1 and 2 are individually 
encapsidated: RNA3 is encapsidated together with RNA4. 
the 876 base subgenomic coat protein message which is 
presumed not to replicate in vivo v. Lane (1974) Adv. Virus 
Res. 19: 15 1). RNA molecules purified from virus particles 
and transcripts prepared from cloned viral cDNA sequences 
are infectious in the barley protoplast model system (F! 
Ahlquist et al. (1984) Proc. Nat. Acad. Sci. USA 81:7066). 
Therefore the full range of molecular biological techniques 
is available for the analysis of BMV nucleic acid functional 
sequences. 
Experimental manipulations of' the cloned BMV genome activity of subgenomic transcription. since in their 
have begun to define regions of functional importance (I? constructs, sequences 5' to the putative promoter were 
Ahlquist and R. French (1988) in Domingo. Holland and missing. No published study has described the use of a 
Ahlquist (eds.) RNA Genetics Book 2: RNA Variability, subgenomic promoter-containing fragment of nucleic acid 
chapter 3. CRC Press. Orlando. Ha.). Both RNAs 1 and 2 5 which could be transferred to a desired new location to 
and their gene products are required for viral RNA synthesis; generate a novel subpenomic mRNA. 
- 
RNAsl and 2 encode nonstructural proteins l a  and 2a 
respectively. and these proteins determine RNA-dependent 
- 
SUMMARY OF THE INVENTION 
& ~ ~ o l ~ & r a s e  activity. RNA3 encodes nonstruct&al pro- The present invention teaches the use of the nucleotide 
tein 3a and coat protein. but neither RNA3. protein 3a, nor 10 sequences which function as a subgenomic promoter of a (+) 
coat protein is required for viral RNAreplication (R. French strand RNA virus to direct the amplified expression of a 
and P. Ahlquist (1986) Science 231:1294). RNA3 can be structural gene in plant tissue, animal tissue or protist cells 
modified by the insertion of a foreign gene in place of the by RNA-dependent RNA polymerase. This is the first 
coat protein gene. or by certain deletions. without the loss of instance wherein the nucleotide sequences identifying the 
replication ability (U.S. patent application Ser. No. 709,181, 1s core region and an upstream activating domain of the 
filed Mar. 7, 1985; R. French et al. (1986) Science subgenomic promoter of a (+) strand virus have been iden- 
23 19294). RNA3 has been well studied because its gene tified. This subgenomic promoter can be utilized in a modi- 
products are not required for RNA replication (French et al, fied virus. a in an appropriately engineered recombinant 
1986). There are regions at the 5' and the 3' noncoding ends cDNA derivative which may be chromosomally integrated 
of the molecule which have homologs on RNAs 1 and 2, and 20 or maintained as an episome in transformed cells. The 
it has been proposed that these sequences may function in invention is exemplified by the subgenomic promoter of 
viral RNA polymerase recognition, initiation of RNA3 of brome mosaic virus (BMV). but the teachings of 
encapsidation. protection of the molecules from cellular the present invention allow a skilled artisan to select and use 
nucleases. or a combination of these functions. Deletion subgenomic promoter sequences from similar (+) strand 
studies using cloned cDNA and in vitro transcripts have 25 RNA viruses for use in any desired cell type. The BMV 
shown that portions of the 5' and the 3' ends are required for subgenomic promoter is composed of two parts: the core 
genomic RNA replication. and that there is a graded effect promoter. identified by the nucleotide sequence from about 
of deletions in the intercistronic region of RNA3 as well (R. -21 to about +16. as in FIG. 2. which is sufficient to direct 
French and F? Ahlquist (1987) J. Virol. 61: 1457). One feature subgenomic transcription. and an activating domain. iden- 
of the intercistronic region is an oligo(A) tract. ranging from 30 tified by the nucleotide sequence from about -95 to about 
14-22 nucleotides in length in natural virus populations (P. -22. as in FIG. 2. The activating domain best acts to increase 
Ahlquist et al. (1981) J. Mol. Biol. 153:23). The subgenomic the level of subgenomic transcription when said activating 
promoter of BMV is located in the intercistronic region as domain is located upstream of and in the proper orientation 
well. Neither the genomic nor the subgenomic promoters of relative to said core promoter. Subgenomic transcription is 
the BMV are recognized by host RNA polymerases; only 35 dependent on RNA-dependent RNApolymerase activity and 
virally infected cells have RNA-dependent RNApolymerase a (-) strand RNA molecule containing the subgenomic 
activity capable of responding to these signals. promoter and the structural gene; for example the BMV 
W. Miller et al., 1985. Nature 313:68, established that the subgenomic promoter is recognized by RNA-dependent 
production of RNA4. which serves as the message for coat RNA polymerase activities encoded by RNA viruses 
protein, occurs by initiation of RNA synthesis within the 40 including. but not limited to. brome mosaic virus and 
RNA3 (-) strand molecule. (-) strand RNA3 templates cowpea chlorotic mottle virus. Further improvements on the 
ending at the BqlII site about 21 bases upstream of the existing art are that upstream duplication of the activating 
RNA4 initiation site were able to direct RNA4 production domain of the subgenomic promoter can increase the level 
(Miller et al. (1985); L. Marsh et al. (1987) in Positive of subgenomic transcription over that directed by a single 
Strand RNA Viruses. New York Alan R. Liss. Inc.. pp. 45 Copy subgenomic promoter and that multiple copies of the 
327-336. These studies and a study by R. French et al. subgenomic promoter can direct the synthesis of more than 
(1986) Science 23 1: 1294. show that deletions and insertions one subgenomic mRNA molecule from one (-) strand RNA 
at or downstream of the SalI site. which is about 17 bases template. 
downstream of the start site. do not interfere with subge- A principal object of the invention is to provide a recom- 
nomic mRNA production. French et al, 1986. demonstrated 50 binant DNA molecule containing a DNA copy of the sub- 
the expression of suitably inserted foreign genes by the genomic promoter of a (+) strand RNA virus and a structural 
subgenomic pathway. Thus. BMV subgenomic promoter gene. wherein the expression of said gene is a two step 
activity was thought to be localized to a 37 base region process: porn of a host cell transcribes a (-) strand RNA 
which in the cDNA clone lies between the BglTI and the SalI molecule carrying the functional sequence of the subge- 
sites. Marsh et al. (1987) also presented evidence from in 55 
vitro experiments that the 5' boundary of the BMV subge- 
nomic promoter activity was not further upstream than the 
BglII site about 21 bases upstream of the RNA4 start site. 
Marsh et al. (1987) also stated, without evidence. that the 
poly(A) tract somewhat further upstream of the RNA4 60 
initiation site improved promoter activity. Both the studies 
by Miller et al. (1985) and those by Marsh et al. (1987) 
utilized in vitro expression experiments to examine the 
requirements of transcription; their results did not indicate 
nomic promoter h d  the cornplemen&y sequence of &d 
structural gene, wherein the synthesis of message-sense 
RNA is under the control of said subgenomic promoter. In 
one embodiment, the subgenomic promoter of RNA3 of 
brome mosaic virus directs the expression of a downstream 
shuctural gene. RNApolymerase I1 of the genetically modi- 
fiedplant tissue synthesizes an RNA molecule which is a (-) 
sense, functional copy of the subgenomic promoter and a (-) 
sense copy of the structural gene. An RNA-dependent RNA 
polymerase, which may be viral RNA replicase of BMV. 
that nucleotide sequence information as far upstream as -95 65 recognizes the subgenomic promoter and synthesizes a (+) 
could contribute to the level of (+) strand mRNA synthesis. sense. or functional message-sense. RNA molecule which 
Neither Miller et al. (1985) nor Marsh et al. (1987) reported can then be translated into protein. The RNA-dependent 
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RNA polymerase activity which responds to the BMV FIG. 4 Effects of 5' deletions on subgenomic promoter 
subgenomic promoter on the (-) strand RNA molecule may activity. The sequence surrounding the 3' proximal RNA 
be from brome mosaic virus or cowpea chlorotic mottle initiation site in derivative pB3SG5. and map of deletions in 
virus genetic information, or from a recombinant DNA derivativespB3SG21.22. and 15 are presentedin this figure. 
molecule encoding, for example. the l a  and 2a genes of 5 pB3SGl1 is the plasmid which represents the undeleted 
BMV. wherein said genes may be translated into protein sequences. Values given for the molar ratios of 
after transcription by RNA polymerase 11 of the host cell in RNU':RNA3 are the averages of two or more independent 
response to either constitutive promoter or under the regu- experiments. 
latory control of a plant regulatory element. FIG. 5 Effects of upstream duplications on subgenomic 
is a further object of the invention to a method lo promoter activity. Map of the intercistronic region of wild- 
for the ampiified gene expression in transformed cells type RNA3 (wt) and sequences duplicated in RNA3 deriva- 
posed of the steps of introducing into a desired host cell a tives pB3IC2. 5. and 6. In each of these derivatives the 
recombinant DNA molecule containing a subgenomic pro- indicated segment of intercistronic sequence is inserted as a duplication immediately 5' to position 1015 in the RNA3 
meter from a (+) strand RNA virus and a structural gene' 
sequence. Values given for the molar ratios of RNA4':RNA3 
wherein of the gene is under the ls are the averages of three independent experiments. For 
control of the subgenomic promoter and wherein the expres- comparison. RNA,$:RNA3 ratios obtained with no duplica- 
sion of that gene depends on transcription by host cellular tions of upstream infomtion are generally about 2.4 for 
RNA polymerase II to yield a (-) strand RNA molecule similar constructions. 
brig the active form of the subgenomic promoter and FIG. 6 Production of multiple subgenomic transcripts 
subsequent subgenomic transcription of the gene to yield 20 individual RW derivatives. schematic maps of ~ A Z  
active- (+) sense by RNA-de~en&nt RNA p l y -  derivatives pB3SG5. 7. 9. 10, 13. and 14. On each line 
merase activity. and then translation of the subgenomic open-hea&d arrows indicate the sites of insertion of addi- 
transcript to produce the polypepti& encoded by the smc- tional copies of the AvaI-Sac1 fragment spanning the RNA4 
turd gene. The host polII transcription can be controlled by initiation site. Above each arrow is given the molar ratio of 
a constitutive. inducible or derepressible polU promoter. 25 that subgenomic RNA to the genomic RNAZ derivative. 
In the figures, and throughout the application. the averaged from two or more independent experiments. Each 
sequences which are the subgenomic promoter are presented value is also represented as a histogram bar for visual 
as the (+) strand sequences, which will be understood to be comparison. Arrows with filled heads represent the unaltered 
the complement of the active subgenomic promoter IWA4 promoter in its w i l d - t ~ ~ e  context. The average ratio 
sequences. 30 of subgenomic RNA4 to genomic RNA3 production in 
wild-type infection under these conditions is 1.2. 
BRIEF D E S C m O N  OF THE FIGURES FIG. 7(A) Alignment of the AvaI-SalI sequence of BMV 
FIG. 1 presents a schematic map of BMV RNM. Nan- RNA3 to emphasize the presence of imperfect direct repeats. 
coding regions are shown as a single line. the 3a and coat This analysis was computer-assisted- The BgII-Sa core 
genes as open boxes, the oligo(A) as a small filled box. and 35 promoter Sequence is shown within the indicated solid box. 
a bent arrow -b the position of the start of sequences The Coat initiation codon. overlapping the site. is also 
encoding subgenomic RNA4. I n  keeping with common mrked. 
practice. the sequence of the packaged (+) strand is shown, FIG. 7(B) Sequence alignment showing the similarity 
but it should be noted that the complementary sequence among BMV. the animal alphaviruses. cowpea chlorotic 
serves as the template for subgenomic RNA synthesis. mottle virus (CCMV), and alfalfa mosaic virus (ALMV) 
Numbering in this figure. and in FIGS. 3, 4, 5. and 6, genomic W A S  near the start of sequences encoding sub- 
corresponds to that in the published sequence for RNA3 (P. genomic mRNAs for capsid proteins. There is a large gap in 
Ahlquist et al. (1981) J. Mol. Biol. 153:23). Restriction each plant virus sequence introduced solely to achieve 
endonuclease sites are recognized on the cDNA molecules alignment with the alphavirus consensus sequence. The bent 
carrying the RNA3 sequences. 45 arrow shows the start of subgenomic RNA sequences and 
FIG. 2 displays the nucleotide sequence of the A V ~ T - S ~  the initiation codons of the BMV and CCMV coat protein 
fragment of the RNA corresponding to the cDNA clone of genes are underlined. These alignments were generated by 
brome mosaic virus RNA3. which fragment comprises the computer using published sequences; in no virus other than 
sequence of the BMV subgenomic promoter and the iaitia- BMV has the actual subgenomic Promoter been e m ~ g c a l l ~  
tion site for subgenomic transcription in the (-1 strand RNA so determined. The alphavirus consensus was derived from the 
molecule. The restriction sites shown are for the correspond- sequences of Sindbis. Middelburg. Sernliki Forest, and ROSS 
ing cDNA. Within the sequences shown the AvaI, Bgll[. and River vhses  (J. -H. OU et d. (1982) ROC. Natl. Acad. SC~.  
SaLI sites bounding the core promoter are overlined and the USA 79:5235). The ALMV RNA.3 sequence is from R- 
coat protein initiation codon and the o l igo (~ )  traa are Barker et al. (1983) Nucleic Acids Res. 11:2881, and the 
underlined. A bent arrow marks the start of the subgenomic 55 CCMVRNA3 sequence was determined by Ahlquist eta] .  
transcript (RNA4). and the sequence of the 5' end of the (1981) Cell 23:183. 
capped RNA4 molecule is given. FIG. 8 presents schematic representations of normal RNA 
FIG. 3 Schematic diagram of the regions the V ~ S  replication an the two-stage expression system which 
coat gene cDNA in plasmids pB3TP8 (wild-type). pB3SG5. utilizes the subgenomic Promoter for amplified transcrip 
and pB3SG6. The AvaI-Sac1 fragment duplicated in 60 tion. 
pB3SG5 is bracketed over the wild-type sequence and FIG. 8A gives the schematic of successive (-) and (+) 
shaded in its new locations in pB3SG5 and pB3SG6. hi- strand synthesis amplifying viral RNAin normal infection of 
tiation sites for subgenomic RNAs 4 and 4' are shown by host cells. 
bent arrows. For pB3SG5 and pB3SG6. the RNA4':RNAZ FIG. 8B gives the schematic for the similar amplification 
ratios were 2.4 and 3.3 respectively. For the wild-type 65 of a chromosomal transcript by cytoplasmic synthesis of 
plasmid and pB3SG5 the RNA4:RNA3 ratios were 1.2 and multiple complementary copies from a viral subgenomic 
0.4. respectively. promoter. 
5,633,447 
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The nontranslatable primary transcript, which itself is a from about -21 to about +17, as in FIG. 2. When correctly 
(-) strand with respect to the coding sequence of the positioned as is understood in the art, the core promoter is 
plant-expressible gene, is synthesized by cellular RNApoly- sufficient to direct the initiation of message synthesis by an 
merase II in response to a p l I I  promoter. RNA-dependent RNA-dependent RNA polymerase so that (+) strand RNA 
RNApolymerase activity, such as that induced by the l a  and s molecules are synthesized. 
2a genes of BMV. is necessary to achieve subgenomic The activating domain of a subgenomic promoter includes 
transcription of a (+) sense directed by the sub@- sequences which increase the activity of the core promoter 
nomic Promoter sequences Present in active form on the (-1 allowing for increased synthesis of subgenomic transcripts. 
strand primary transcript RNA molecule- The plant tissue In the case of BMV. the activating domain which can 
can be genetically mdified to contain the gene(s) encoding 1 0  increase synthesis of mRNA directed by a subgenomic 
RNA-d'Tendent RNA ~ol~merase  activity under the regu- promoter. or a subgenomic core promoter. relative to the 
l a t o ~  control of RNA polymerase IL or that activity can be levels obtained when only the core promoter sequences are 
expressed during viral infection. Because the polarity of the present, comprises the nucleotide sequence between about 
primary transcript is opposite to its product subgenomic -95 and about -22. as in FIG. 2. Somewhat less activation 
RNA, translation of appropriately oriented genes only 1 s  is obtained with the sequence from about -74 to about -22. 
Occurs from the subgenomic Thus. this RNA dependent RNApolymaase herein refers to an RNA 
scheme provides of induction as as synthetic enzyme which faithfully initiates (+) strand RNA 
expression. synthesis in response to an RNA sequence which is a 
DETAILED DESCRIE'TION OF THE subgenomic promoter. and which is contained within a RNA 
m O N  20 molecule which is (-) sense relative to the coding region of the associated structural gene. For example. the la and 2a 
The following definitions are provided. in order to remove genes of BMV determine -kN~-dependen;RN~ polymerase 
ambiguities to the intent of scope of their usage in the activity in cells within which those genes are expressed. and 
specification and claims. that RNA-dependent RNA polymerase activity recognizes 
A,, RNA virus, as used herein, means a virus whose 25 subgenomic promoters including. but not limited to. those of 
genome is RNA in single-stranded form, the sing,e strand brome mosaic virus and cowpea chlorotic mottle virus. 
being a (+). or messenger-sense strand. Replication of the The term subgenomic transcription refers herein to the 
viral (+) strand in a cell occurs by a process of direct RNA synthesis of RNA by an RNA-dependent RNA polymerase 
replication and is therefore distinguishable from the mecha- 30 wherein said RNA-dependent RNA polymerase uses a (-1 
nism of retroviral replication which is characterized by an strand of RNA as template. and wherein said RNA- 
intermediate step of reverse transcription in the host cell. dependentRNApolymerase initiates the synthesis of mRNA 
The term subgenomic promoter refers to those sequences in response to the nucleOtide sequence Con- 
within an RNA molecule and at the 5' end of a structural tained within the subgenomic promoter. 
gene. which direct messenger RNA synthesis using said 3 s  The term (+) strand RNA refers to RNA which is 
RNA molecule as the template. A subgenomic promoter is messenger-sense with respect to coding regions- 
necessary to drive expression of genes using RNA as tem- The term (-) sense RNArefers to sequences which are the 
plate; the subgenomic promoter is recognized by an RNA- complement of (+) sense molecules. For example. the (-) 
dependent FWA polymerase, which may be a viral RNA sense RNA molecule corresponding to a structural gene is 
replicase. The promoter itself may be a composite of seg- 40 complementary in sequence to the message. and the (-) 
ments derived from more than one source. naturally occur- sense RNA molecule cannot itself act as a message for the 
ring or synthetic. It should be noted that a subgenomic translation of the corresponding protein. 
Homoter is located in relation to the particular gene whose The term polII promoter herein refers to DNA sequences 
b-anscription it initiates. and it is functionally recognized by at the 5' end of genes which direct the initiation of wan- 
an RNA-dependent RNA polymerase (or viral RNA 45 scription by the DNA-dependent enzyme RNApolymerase 
replicase) when it is contained within an RNA molecule of of plant or animal cells. Promoter sequences are necessary, 
the Proper (-1 polarity. The (-1 sense W A  ~olecule  con- but not always suEicient. to drive the expression of down- 
taining the functional COPY of the subgenomic promoter. stream genes. The promoter itself may be a composite of 
which comprises the functional units of core promoter and segments derived from more than one source. naturally 
activating domain. can be synthesized by WA-dependent so occurring or synthetic. Eukaryotic polII promoters are com- 
RNA polymerase using a (+) sense RNA molecule as monly identified by the presence of DNA sequences 
template. or it may have been synthesized by (cehdar) RNA homologous to the canonical form 5'-TATAA-~' ('TP;TKA' 
plymerase II as a transcript initiated by a Promoter- A box) about 10-30 bp 5' to the location of the 5'-end of the 
specific embodiment of the present invention is the subge- ~ R N A  (cap site, +I).  bout 30 bp 5' to the TATA box 
nomic Promoter of RNA3 of brome mosaic virus (BMV). 55 another promoter component sequence is often. but not 
The identifying sequence of the subgenomic promoter of always. found which is identilied by the presence of DNA 
BMV is given in FIG. 2. For consistency herein. the position sequences homologous to the canonical form 5'-CCAAT-3'. 
of the brome mosaic virus subgenomic Promoter has been For the purposes of the present description. a pol11 promoter 
given relative to the start site of the subgenomic mRNA. is &fined to include DNA sequence extending up to about 
which is designated The BMV subgenomic Fomoter 60 100 bp 5'(-100) to the cap site. Any additional sequences 
comprises the nucleotide sequence extending from about which may be located 5' to -100, and which may contain 
-95 to about +17. as in FIG. 2; the sequence comprised functionality including, but not limited to. that of &anscrip 
within the region from about -74 to about +16 also consti- tion activating element or sequences exerting regulation in 
tutes a functional subgenomic promoter. response to environmental stimuli. are considered promoter- 
The core promoter of a subgenomic promoter includes the 6 5  associated elements. but for the purposes of this application. 
minimum sequence required for function. In the case of are considered part of the pol11 promoter. even though said 
BMV the core promoter comprises the nucleotide sequence sequences may be recognized by cellular proteins other than 
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DNA-dependent RNA polymerase 11. (A polymerase is said various forms of aggregations of plant cells in culture such 
to "recognize" a particular DNA sequence if that sequence as embryos and calli. The plant tissue may be in planta. or 
is necessary to or has regulatory effect on initiation of in organ, tissue. or cell culture. 
transcription by the polymerase.) It should be noted that a The term chemically synthesized. as related to a sequence 
pol11 promoter is generally located 5' to the particular gene 5 of DNA. means that the component nucleotides were 
whose transcription it initiates. That transcript may be a (+) assembled in vitro using nonenzymatic means. Manual 
sense RNAmolecule which can serve as a message or it may synthesis of DNA may be accomplished using well estab- 
be a (-) strand RNA molecule which can serve as a template lished procedures (i.e. M. Caruthers (1983) in Methodology 
for subsequent RNA synthesis. of DNA and RNA Sequencing. Weissman (ed.). Praeger 
Expression refers to the transcription and translation of a lo mfblishers (New York) Chapter 1) or automated synthesis 
structural gene so that a protein is made. Gene expression can be performed using one of a number of commercially 
can be assessed by direct detection of the protein product, by available machines. 
protein gel electrophoresis or immunological methods, for Homlogy as used herein. refers to identity of nucleotide 
example. Oftentimes, expression is assessed by detection of sequences. The extent of homology between DNA 
the mRNA products of transcription. This method is par- l5 sequences can be empirically determined in DNA hybrid- 
titularly appropriate for the assessment of transcriptional ization experiments, such as those described in B. Hames 
control factors. such as promoter elements, since the effects and S. Higgins (1985) Nucleic Acid Hybridization. IRL 
of nontranscriptional processes, such as protein degradation. Press. Oxford. UK. 
are excluded. Because there is some flexibility with respect to the 
A structural gene refers to the combination of nucleotide 20 sequences canied on BMV RNA3. it was possible to exam- 
sequences encoding a protein and (some of) the regulatory ine how certain RNA sequences in the intercistronic region 
sequences which allow expression of that structural gene in contributed to subgenomic promoter activity. It was known 
a plant cell or tissue. The term structural gene refers to that that initiation of subgenomic RNA synthesis does not 
portion of a gene composed of a DNA segment coding for require more than 16 bases downstream of the start site (i.e. 
a protein. polypeptide or portion thereof. possibly including 25 3' to the start of RNA4 sequences in the virion-sense RNA) 
aribosome binding site andlor translational start codon. The (W. Miller et al. (1985) Nature 313:68; R. French et al. 
term can also refer to copies of a structural gene naturally (1986) Science 231:1294; L. Marsh et al. (1987) in Positive 
found within the cell. but artificially introduced. In this case Shand RNA Viruses, Man R. Liss, Inc., New York. pp. 
a structural gene naturally found in a cell may be reintro- 327-336). Infectious in vitro transcripts synthesized from 
duced into a cell as part of a chimeric gene having non- 30 engineered RNA3 cDNA clones were used to determine the 
natural regulatory control sequences. for example under the effects of alterations in the primary structure of RNA3. A 
control of the BMV subgenomic promoter. The structural restriction map of the cDNA clone of BMV RNA3 and the 
gene may encode a protein not normally found in the plant nucleotide sequence of the AvaI-SalI region surrounding the 
cell in which the gene is introduced, in which case it is subgenomic transcript start sites are given in FIGS. 1 and 2. 
termed a foreign structural gene. A foreign structural gene 35 A notable feature of the sequence upstream from the sub- 
may be derived in whole or part from a bacterial genome or genomic message start site is an oligo(A) tract which is 
episome. eukaryotic nuclear or plastid DNA, cDNA. viral conserved at equivalent genomic positions in other members 
DNA. or chemically synthesized DNA. It is further contem- of the bromovirus group (P. Ahlquist et al. (1981) Cell 
plated that a structural gene may contain one or more 23:183: unpublished observations). To determine whether 
modifications in either the coding segments or in the 40 the oligo(A) tract affects subgenomic promoter activity. 
untranslated regions which could affect the biological activ- mutant plasmid pB3IC4. which lacks all but one A residue. 
ity or the chemical structure of the expression product. the was constructed. That in vitro RNA3 transcript possessed 
rate of expression, or the manner of expression control. Such less than 10% of the parental subgenomic promoter activity 
modifications include. but are not limited to, insertions. in Viro. The length of the oligo(A) tract ranges in length 
deletions and substitutions of one or more nucleotides. The 45 from 16-22 in natural RNA3 populations (P. ANquist et al. 
structural gene may constitute an uninterrupted coding (1981) J. Mol. Biol. 153:23). In pB3TP8 there are 18 A 
sequence or it may include one or more introns. bounded by residues (M. Janda et al. (1987) Virology 158:259). Subge- 
host cell-functional splice junctions. The structural gene nomic promoters containing oligo(A) tracts differing in 
may be a composite of segments derived from a plurality of length from the 18 as in FIG. 2. will be considered func- 
sources. naturally occumng or synthetic. That structural 50 tionally equivalent to the BMV subgenomic promoter of 
gene may also produce a fusion protein. It is contemplated FIG. 2. provided that similar amounts of sequence informa- 
that the introduction into host cells of recombinant DNA tion flanking the oligo(A) are maintained. 
containing the structural gene in combination with a subge- I, the test system. parental RNA_~ transcripts produced 
nomic promoter or with a pollI promoter will include progeny (+) strand RNAS at a ratio of RNA4:RNAZ of 1.2. 
constructions in which the structural gene is not derived 55 To separate the effects of sequence changes in the intercis- 
from the same kind of cell as the host. and constructions tronic region on subgenomic message production from 
wherein additional copies of naturally occurring genes are effects on genomic RNA~ amplification. a second subge- 
expressed under BMV subgenomic promoter control. nomic initiation site was established by inserting the AvaI- 
A recombinant DNA molecule is one which has been Sac1 fragment of cDNA spanning the start site at the XbaI 
either naturally or artificially produced from parts derived 60 site of the RNA3 cDNA to create pB3SG5 (FIG. 3). pB3SG5 
from heterologous sources. which parts may be naturally transcripts were replicated, and directed the synthesis of two 
occurring or chemically synthesized molecules. and wherein subgenomic RNAs as intended. The subgenomic mRNA 
those parts have been joined by ligation or other means produced from the engineered copy of the subgenomic 
known to the art. promoter (RNAC) was more abundant than both the 
Plant tissue includes differentiated and undifferentiated 65 genomic RNA3 and the subgenomic mRNA originating 
tissues of plants including, but not limited to, roots. shoots. from the wild-type subgenomic promoter. A ratio of 
leaves. pollen. seeds. tumor tissue such as crown galls. and RNA4':RNA3 of 2.4: 1 was obtained from pB3SG5. 
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pB3SG6. which contained only one copy of the subgenomic fragment was present, the AvaI-Sac1 fragment of RNA3 was 
promoter at the same distal location as that of pB3SG5. duplicated at a ClaI site 5' to the normal RNA4 start site in 
produced subgenomic and genomic RNAs at a ratio of 2.5: 1. pB3SG7. Both subgenomic promoters were functional, and 
The sizes of subgenomic RNA species obtained with as in other cases where there were two copies of the 
pB3SG5 and pB3SG6 were consistent with initiation from 5 subgenomic promoter. the smaller of the subgenomic RNAs 
the expected sites in the duplicated promoter sequences. was more abundant. Mutant RNA3 cDNA clones were also 
Primer extension experiments confirmed that the initiation constructed to test whether more than two subgenomic 
site for subgenomic RNA synthesis was unchanged even promoters were functional in a single RNA3 derivative. 
when the subgenomic promoter was moved to a new loca- pB3SG9 and pB3SG10 each contained two AvaI-Sac1 sub- 
tion or was duplicated within the RNA3 cDNA clone. Like lo genomic promoter fragments while pB3SG13 and pB3SG14 
wild-type RNA4 (R. Dasgupta et al. (1976) J. Viral. 18:260), each contained three. It was found that the subgenomic 
the subgenomic RNA produced from the novel subgenomic promoter was active at each location tested. and a distinct 
RNA initiation site was capped. gradient favoring greater accumulation of subgenomic 
Further functionality of RNA sequences in the region WAS from 3' proximal sites was observed in these experi- 
upstream of the subgenomic RNA start site was examined by 15 ments (FIG. 6). The observed activation of subgenomic 
determining the effects of a series of internal insertion and transcription is a consequence of upstream duplications of 
deletion mutations on subgenomic mRNA synthesis in plant subgenomic promoter components. 
tissue. A second functional subgenomic promoter was estab- The ability of the subgenomic promoter fragment to lished distal to the intercistronic region; therefore. it was function in the reverse orientation relative to the surrounding possible to use deletion analysis to investigate the 5' limits 2o cDNA was tested in pB3SGSR and pB3SG6R. No putative 
of sequences contributing to subgenomic RNA synthesis 
without significant affects on full-length R N A ~  accumula- subgenomic RNA species were observed. In both cases the 
tion. In protoplast infedions these deletions induced an inversion caused severe inhibition of RNA3 accumulation. 
obvious progressive decline in subgenomic RNA production For SG6R. with its 26 b inverted repeat. a amount 
as the deletions extended further 5'. The decreased accumu- of could be detected on overexPosures of the 
lation must reflect reduced synthesis because the sequence 25 autoradiogra~hs. but SGSR with its 330 bp inverted repeat 
of the subgenomic RNA, and therefore its stability. was never gave detectable RNA3 production. NO internally ini- 
unchanged in the various constructions. The results are tiated "pseudo-subgenomic" RNA species of negative polar- 
summarized in FIG. 4. pB3SGl1 carried the AvaI-SalI ity were detected from either construction. 
fragment containing about 95 bases upstream of through Computer-assisted sequence inspection revealed that the 
about 16 bases downstream of the start of subgenomic 30 120 base AvaI-SalI region of the RNA3 cDNA. which 
transcription. The RNA4':RNA3 ratio of 2.5 was similar to contains the core promoter and the activating domain of the 
that of pB3SG5. which carried the sequence information subgenomic promoter, includes several imperfect direct 
through the Sac1 site well into the coat protein gene. repeats (FIG. 7). The 30 bases overlapping and immediately 
pB3SG21. containing subgenomic promoter sequences from 5' to the oligo(A) tract have 67% identity with the BgLII-SalI 
the BstXI site about -74 through the SalI site downstream of 35 core promoter region. with the 3' boundary of this duplica- 
the start site. produced an RNA4':RNA3 ratio similar to the tion corresponding precisely to the start of the coat protein 
RNA4:RNA3 ratio of the wild-type plasmid, but lower than coding region. Immediately 5' to this duplication is a clearly 
that of pB3SG11. Further deletions of the upstream region related segment which also includes a single-mismatch 
gave further decreases in the R N A 4 ' : W  ratios. pB3SG15 repeat of the consensus element 5'-AUCUAUGUU-3'. Thus. 
was the plasmid with the shorlest subgenomic promoter 40 nearly all of the AvaI-SalI promoter region consists of 
fragment (BglII-SalI); the RNAC:RNA3 ratio was 0.3:l. repeats or partial repeats of sequences related to the core 
showing that the efficiency of the truncated subgenomic promota; punctuated in one area by the oligo(A). Although 
promoter was limited. Thus. the 5' end of the core promoter similar in sequence, the two copies of the core promoter 
is no further 5' than -21. and all information necessary for motif flanking the oligo(A) were clearly not equivalent. 
efficient initiation is 3' to about -95. with results similar to 45 While the 3' copy contains a weak but functional promoter, 
that of the wild-type plasmid ratio when only about 74 bases no subgenomic RNA initiation was detected at the corre- 
of upstream information are present. Therefore, the BglII- sponding site in the 5' copy of this motif. 
SalI fragment. from about -21 to about +16 as in FIG. 2. As shown in FIG. 7. the oligo(A)/core promoter region of 
comprises the BMV subgenomic core promoter. The AvaI- BMV WA'j  contains similarities to the analogous regions 
SalI fragment, from about -95 to about +16. as in FIG. 2. 50 near the subgenomic mRNA start sites in some other plant 
and the BstXI-Sd fragment, from about -74 to about RNA viruses. including cowpea chlorotic mottle virus 
as in HG. 2. both contain activating domain and core (CCMV) and alfalfa mosaic virus (AMV), BMV is the only 
promoter activities of the subgenomic promoter. (+) strand RNA virus for which the subgenomic promoter 
Duplication of subgenomic promoter activating domain sequences have been determined experimentally. FIG. 7 also 
sequences from the RNA3 intercistronic region at a site 55 displays the significant homology of the sequence from the 
some 220 bases upstream of the start site for subgenomic BMV subgenomic promoter region to the consensus 
transcription led to a stimulation in subgenomic RNA syn- sequence from just upstream of the start of alphavirus 
thesis. The structures and the RNA4:RNM ratios for wild- subgenomic RNA (taken from J. -H. Ou et al. (1982) Proc. 
type and the mutant plasmids is given in FIG. 5. Significant Natl. Acad. Sci. USA 79:5235-5239); the functionality of 
stimulation of subgenomic RNA synthesis was achieved by 60 the alphavirus consensus sequence in directing subgenomic 
duplicating the sequence contained within the activating RNA synthesis has not been tested. The sequence similari- 
domain. an AvaI-BglII fragmenl from about -95 to about ties shown in FIG. 7 overlap the BMV consensus element 
-21 of the cDNA of RNA3 upstream of RNA start site. AUCUAUGUU which. with single mismatches. is repeated 
While the oligo(A) tract contributed to that stimulation. it three times in the BMV AvaI-SalI fragment (FIG. 7A). 
was not required for stimulation to occur. 65 Deletions of the upstream repeated sequences (FIG. 4) 
To determine whether sites other than the XbaI site could resulted in decreased subgenomic promoter activity. 
support subgenomic RNA synthesis when the AvaI-Sac1 Furthermore. RNA4 synthesis was shown to proceed cor- 
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rectly from a CCMV RNA3 when BMV RNAs 1 and 2 were 
provided in a co-infection and similarly. co-infections of 
BMV RNA3 with CCMV RNAs 1 and 2 yield accurately 
synthesized RNA4. Previously published studies of BMV 
subgenomic transcription were based on in vitro experi- 
ments carried out using extracts made from BMV-infected 
barley cells (L. Marsh et al. (1987) in Positive Strand RNA 
Mruses. Alan R. Liss, Inc.. New York; W. Miller et al. (1985) 
Nature 313:68). The work of the present invention was 
performed using in vivo experiments to study subgenomic 
RNA synthesis. The current results demonstrate that the 
BgllI-SalI region of cDNA for BMV RNA3 has some 
subgenomic promoter activity in vivo, however, sequence 
information upstream of the BgLII site (the AvaI-BglII region 
from about -95 to about -21 relative to the start site) 
constitutes an activating domain which is required for effi- 
cient synthesis of subgenomic RNA by RNA-dependent 
RNA polymerase. In addition. the work of the present 
invention demonstrated that a fragment of DNA (e.g., the 
AvaI-SalI fragment) containing the subgenomic promoter 
could be moved to a novel location within an RNA sequence 
with subgenomic promoter activity retained. Furthermore. 
several subgenomic promoters have now been shown to be 
functional within a single RNA3 derivative even if located 
at separate sites leading to a plurality of subgenomic RNA 
transcripts. Still further, it was determined that a fragment 
carrying the activating domain of a subgenomic promoter 
could be duplicated upstream of the subgenomic promoter 
with the unexpected result that subgenomic transcription 
was enhanced. 
A principal feature of the present invention is the brome 
mosaic virus subgenomic promoter. which is identified by 
the nucleotide sequence as in FZG. 2, nucleotides -95 to +16 
relative to the start site for subgenomic transcription. This 
nucleotide sequence was sufficient to direct subgenomic 
RNA synthesis from a novel site on the viral genome at 
wild-type or greater levels. Sequences no more than about 
20 bases upstream of the start site sufficed to direct specific 
initiation at a low level; therefore the region between -21 
and +16 is termed the subgenomic core promoter. Sequences 
at least as far as 74, but no more than 95 bases upstream are 
required for full promoter activity. The oligo(A) tract within 
the region between -21 and -74 is an important functional 
element in full subgenomic promoter activity, and may 
function as a recognition sequence element or may provide 
spacing or flexibility between other elements of the pro- 
moter. The function of the sequence elements with homol- 
ogy to the consensus element AUCUAUGUU is not known. 
but analogy to DNA-dependent transcription suggests that 
these sequences might be recognized by trans-acting factor 
(s) to increase the level of subgenomic transcription. Further 
increases in the level of subgenomic transcription were 
obtained by duplicating the sequence information of the 
AvaI-BgHl fragment upstream from the start site. as in FIGS. 
2 and 5. The subgenomic promoter can be used to direct the 
expression of a structural gene when the subgenomic pro- 
moter is in a site other than its normal site within the RNA3 
derivative. and enhancement of subgenomic transcription 
may be achieved by duplication of the activating domain 
portion of the subgenomic promoter. 
From the data presented herein. location. isolation and use 
of subgenomic promoters from other sources can be readily 
carried out by those of ordinary skill in the art without undue 
experimentation. The comparative sequence data of FIG. 7 
show remarkable homology over a wide range of RNA 
sources known to possess subgenomic promoters. From 
such data, together with known or readily obtainable data on 
subgenomic transcription start sites. subgenomic promoters 
equivalent to that of BMV RNA3 can be isolated and used 
as described and exemplified herein. The recognized homol- 
ogy and mode of action of RNA-dependent FZNA p l y -  
5 merases allows for the mixed combination of subgenomic 
promoter and RNA-dependent RNA polymerase from het- 
erologous sources, or demonstrated herein for BMV and 
CCMV. However, it will be understood that merences in 
rate of transcription and promoter specificity can lead to 
lo quantitative differences h expressiA. depending on the 
particular combination of promoter and polymerase 
employed. 
It is an object of this invention to provide a method for the 
amplified expression in plant tissue of a structural gene 
1s under the regulatory control of an FZNA virus subgenomic 
promoter. which in one embodiment can be the subgenomic 
promoter of brome mosaic virus. The method is composed 
of the following steps: introducing into plant tissue a recom- 
binant DNA molecule containing the subgenomic promoter 
20 and a structural gene such that the expression of said gene 
is under the regulatory control of the subgenomic promoter 
and the entire combination is of a conventional polII 
promoter. either constitutive. inducible or derepressible. 
synthesis by cellular RNA polymerase 11 of a prinmy. (-) 
25 strand transcript containing the subgenomic promoter in its 
active form and the complement of the coding sequence of 
the structural gene. and expression of FZNA-dependent RNA 
polymerase activity (for example, by the infection of the 
modified plant tissue with brome mosaic virus, or by induc- 
30 ing chromosomally integrated copies of the BMV la and 2a 
genes under the control of pol11 promoters). followed by 
subgenomic transcription to yield a secondaq. (+) sense 
mRNAencoding the structural gene which is then translated 
to yield its protein product. This scheme has the advantage 
35 that in the absence of RNA-dependent RNA polymerase 
activity the structural gene is completely silent because there 
is no (+) sense RNA synthesized. and therefore. there can be 
no translation to yield the protein product of that gene. 
Generally genes under the regulatory control of regulated 
40 polII promoters and associated sequence elements exhibit 
some degree of expression even in the absence of inducing 
conditions. Use of a subgenomic promoter is therefore 
useful to prevent expression of a gene which would be lethal 
for the cell which expresses it. When such a gene is tightly 
45 controlled so that it is only expressed after infection with 
virus, its expression kills the infected cell before virus 
replication and dissemination occur. This process constitutes 
an effective means for controlling virus infection in plant 
tissue, and therefore a way to prevent crop damage and 
50 economic loss. The advantages of this scheme would be lost 
if the control of lethal gene expression were not virtually 
absolute, and are therefore not feasible with prior art pol11 
promoters. 
Another consequence of the use of a subgenomic pro- 
ss moter is the rapid amplification of expression once an active 
RNA-dependent RNA polymerase is present. The promoter 
is therefore useful to express any gene when a sudden burst 
of expression is desired. For example. rapid but transitory 
expression of high-level herbicide-resistance can be 
60 obtained by providing a herbicide-resistance gene under 
subgenomic promoter control and an RNA-dependent RNA 
polymerase under control of an inducible or derepressible 
polII promoter. The latter can be chosen to turn on p l y -  
merase expression in response to a component in the her- 
65 bicide formulation. Other specific resistances can be regu- 
lated in a similar manner and will be especially useful where 
the resistance is the result of expressing a gene that leads to 
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production of a toxic distasteful or otherwise undesirable lar biology, in the manipulation of recombinant DNA in 
substance. High level. transitory expression of such a gene plant tissue, and in the culture and regeneration of trans- 
can be achieved using an innocuous inducing agent, so as to formed plants. Techniques for similar manipulations of 
produce the desired resistance at precisely the desired Stage recombinant DNA in animal and bacterial cells are well 
in the host organism's life cycle. Later. for example at 5 known. Enzymes are obtained from commercial sources and 
harvest. when the gene is not expressed, the undesirable are used according to the vendors' recommendations or 
substance is absent from plant tissue intended for consump other variations known in the art. R ~ ~ ~ ~ ~ ~ ~ .  buffers. 
tion. cultural conditions are also known to the art. References 
It will be understood by those of ordinary skill in the art containing standard molecular biological procedures include 
that the use of subgenomic promoter-structural gene corn- lo T. Maniatis et al. (1982) Molecular Cloning. Cold Spring 
binations is not confined to plants. Positive strand RNA Harbor ~ ~ b ~ ~ ~ ~ ~ ~ .  cold spring ~ ~ b ~ ~ .  N.Y; R. wu (ed.) 
viruses exist for bacteria and animal cells as well as plants, (1979) ~ ~ t h .  ~ ~ ~ ~ ~ ~ l .  68; R. wu et al. (eds.) (1983) 
and subgenomic promoter homology is seen for both plant 
~ ~ ~ ~ ~ ~ l .  100 and 101; L. eossman and K. 
and animal viruses. of a structural Moldave (eds.) Methods Enzymol. (1980) 65; J. Miller (ed.) 
gene under subgenomic Promoter control can be axom- 15 (1~r72) E q e h n t s  in Molecular Genetics. Cold Spring 
plished in any transformable cell including. without ~~b~ ~ b ~ ~ ~ ~ ~ ~ ~ ,  cold spring ~ ~ b ~ .  N.Y; old and 
limitation, plant cells, animal cells and bacterial cells. Primrose (1981) Principles of Gene Manipulation, Univer- 
The production of genetically modified plant tissue con- sity of California Press, Berkeley, Calif.; R. Schlief and P. 
taining and expressing a structural gene under the banscrip Wensink (1982) Practical Methods in Molecular Biology, 
tional control of the BMV subgenomic Promoter combines 20 Springer-Verlag. Berlin; Glover (ed) (1985) DNA Cloning, 
the specific teachings of the present disclosure with a variety ~01s. I and 11. Press, Oxford, IJK; B. Hames and S. 
of techniques and expedients known in the art. In most Higgins (eds.) (1985) Nucleic Acid Hybridization, IRL 
instances. alternative expedients exist for each Stage of the Press, Oxford, UK; p, Setlow and A. Hollaender (1979) 
process. The choice of expedients depends on variables such Genetic Engineering: Principles and Methods, Vols. 1-4. 
as the choice of vector system for the introduction and stable 25 Plenum Press, N.Y. Abbreviations and nomenclature. where 
n~aintenance of the expression complex. the cell type, employed. are deemed standard in the field and commonly 
whether plant, animal or protist, to be modified and, in the used in professional journals such as those cited herein. 
case of plants, the desired regeneration strategy, and the 
micular  structural gene to be used, all of which wesent EXAMPLE 1 
iternative process s h s  which those of ordinary skiil in the 30 
art are able to select and use to achieve a desired result. This example describes the recombinant DNA molecules 
and the cloning strategies used to characterize the BMV Homologs of structural genes or of other sequences may 
subgenomic promoter sequences. be identified by the ability of their nucleic acids to cross- 
hybridize under conditions of appropriate stringency as is 
well understood in the art. It will be understood that there 
may be minor sequence variations within sequences utilized 
or disclosed in the present application. It is well known in 
the art that some DNA secluences within a larger stretch of 
sequence are more impokant than others inVdetermining 
functionalitv. A skilled artisan can test allowable variations 
in sequence, without undue experimentation. by well known 
mutagenic techniques which include. but are not limited to. 
those discussed by D. Shortle et al. (1981)Ann. Rev. Genet. 
15265; M. Smith (1985) ibid. 19:423; D. Botstein and D. 
Shortle (1985) Science 229:1193; by linker scanning 
mutagenesis (S. McKnight and R. Kingsbury (1982) Science 
217:316) or by saturation mutagenesis (R. Myers et al. 
(1986) Science 232:613). These variations may be deter- 
mined by standard techniques in combination with assay 
methods described herein to enable those skilled in the art to 
manipulate and bring into utility the functional units of pol11 
promoters, structural genes. and subgenomic promoters. 
Using the methods described herein the skilled artisan can. 
without undue experimentation, test altered sequences 
within a subgenomic promoter for retention of function. The 
final steps of the preferred embodiment for obtaining geneti- 
cally modified plant tissue include inserting the expression 
complex into a T-DNA-containing vector, and transferring 
the recombinant DNA to plant tissue wherein the modified 
T-DNA becomes stably integrated as a part of the genome. 
Other techniques for transforming plant cells. including 
protoplast transformation. elecb-oporation, micro-injection 
and agroinfection can be employed. 
The following examples are provided for illustrative 
purposes only and are not intended to limit the scope of the 
invention. The examples utilize many techniques well 
known and accessible to those skilled in the arts of molecu- 
1.1 Wild-type cDNA Clones of Brome Mosaic 
V i s  in Transcription Vector Plasmids 
Plasmids pBlTP3. pB2TP5, and pB3TP8 contain cDNA 
copies of BMV RNAs 1. 2, and 3, respectively, from which 
properly initiated, capped and infectious transcripts of the 
complete BMV genome can be produced with T7 RNA 
polymerase (M. Janda et al. (1987) Virol. 158:259). Other 
plasmids used in the construction of RNA3 derivatives were 
pB3TP7 (M. Janda et al. (1987) and pB3PM1 (P. Ahlquist 
and M. Janda (1984) Mol. Cell. Biol. 4:28762882). Those 
plasmids contain the same BMV cDNA region as pB3TP8. 
but are linked to a T7 promoter with a single intervening G 
residue, and linked directly to an E. coli promoter, respec- 
tively. All the above plasmids except pB3M1 are pUC119 
derivatives, and so contain the ssDNA replication origin of 
bacteriophage M13. allowing recovery of ssDNA forms 
after superinfection with suitable helper phage. such as 
M13K07 (provided by J. Vieira). 
1.2 Plasmid Constructions with Mutant BMV 
Constructions 
Standard methods were used with minor modifications (T. 
Maniatis et al. (1982) Molecular Cloning. Cold Spring 
Harbor Laboratory, Cold Spring Harbor. N.Y.). To join 
noncomplementary ends of fragments produced by different 
restriction endonucleases. 3' protruding ends were trimmed 
to bluntness with T4 DNA polymerase. and 3' recessed ends 
were extended to bluntness with either the large fragment of 
E. coli DNA polymerase I or T4 DNA polymerase. 
pB3IC4: E. coli RZ1032 (dut. ung) (T. Kunkel (1985) 
Proc. Nat. Acad. Sci. USA 82:488) was transformed with 
pB3TPs and dUTP-containing ssDNA was isolated after 
superinfection with M13K07. This DNA was used as a 
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template for oligonucleotide-directed mutagenesis (Kunkel. transcription in the presence of m7GpppG or GpppG, pro- 
1985) to delete 17 of the 18 residues of the pB3TP8 toplast inoculation and incubation. viral RNA extraction and 
intercistronic 0ligNA) tract, and the product clones were analysis and densitometry of the resulting autoradiographs 
screened di&Ox~nucleoti& sequencing (M. Biggen were carried out as described (French and Mquist, 1987). (1983) Proc. Nat. Acad. Sci. USA 80:3%3). The mutagenic s Each plasmid construction was tested in at least three 
o l igonuc leo t ide  used W a s  independent experiments. Probes for the (+) strand FWA 
$ ~ g ~ ~ " , ~ ~ ~ e d ~ ~ ~ ~ ~ ~ ~ f ~ ~ ~ ~ ~ , " ~ f  were a 32P-labelled SP6 transcript from subclone pB3HEl. 
boundaq of the core promoter. pB31C4 is the plasmid which which the 200 base Hinm-EcoRT of 3' 
la& the oligo(A) tract in the subgenomic promoter region. 10 terminal RNA3 sequences from pB3TP8. Or in 
pB3SG5. 5R, 9. 10, ll, 13, 14, 15, 21, 22: Copies of the tain experiments (e.g.. for F'IG. 6 of MS) a similar in vitro 
Avd-SacI fragment of p B 3 m  were inserted as duplica- ''mplementar~ to the Bgm-Sacll region of 
tions in the indicated sites of the RNA3 ,-DNA region of RNA3. Denaturing gel for negative strand 
p B 3 m :  pB3SG5: Xbd; pB3SG7: ClaI; pB3SG9: ClaI. RNA analysis was carried Out On genes 
~ b * ,  pB3SG10: x b a ~ s t u l ;  pB3SG13; c l d  xbal, stul; 1s (Maniatis et al.. 1982). Probes for the negative strand RNAs 
pB3SG14: N ~ ~ I ,  a d ,  su ~ ~ ~ ~ ~ i ~ t i ~ ~  analysis was used to were in vitro transcripts from subclones covering the AvaI- 
select those insertions with the same orientation as the Sac1 region of BMV RNA3- 
surrounding cDNA. Multiple rounds of cloning were Primer extension experiments were carried out after 
required to construct those dexivatives with multiple inser- 20 inoculation of 106 ptoplasts with transcripts of FWAl and 
tions of the subgenomic promoter fragment. In the cases of RNA2 cDNA clones @B1m and pB2TP5) and transcripts 
multiple promoter constructions, the use of the AvaI-Sac1 
of the appropriate RNA3 cDNA clone. incubation for fragment rather than the smaller AvaI-SalI fragment allowed 
the distinction of the resulting subgenomic RNA species 24 h under continuous light, total nucleic acids were isolated 
differentiable in size by gel electrophoresis. and dissolved in 15 pl ddH20. 1.5 pl of this nucleic acid was 
25 mixed with 1 ng of 5 '-32P l abe l l ed  P~~~~~~ contains the AvaI-Sacl in the reverse d(GCGAGTCm(-'TITACC) (complementruy to bases 28-42 
orientation at the XbaI site of pB3TW. 
of BMV RNA4) in a total volume of 4 pl with 1.5 units of 
pB3SG11 contains the AvaI-SalI fragment as a duplica- reverse transcriptase (Life Sciences. Inc.) deoxynucleotides 
tion at the site of P B ~ T P ~ .  Similarly. pB3SG15. 
at 25 each. and final concentrations of 25 mM Tris-cl 
P ~ ~ ~ ~ ~ ~ *  and P~~  contain the B@-SaLT. BsX1-Sall, and 30 pH 8.3. 5 &f MgCl,, 25 &f KC1 . and 5 &f m. After 
D&I-SalI fragments. respectively. incubation for 30 min. at 37 C., the products were denatured 
pB3SG6.6R: pB3BB1 is a p B 3 m  derivative in which a at 95 C. for mino in an equal volume of 908 &letion from base the downstream site has 20 mM EDTA. 0.1% xylene cyanol. 0.1% bromphenol blue. been i~~trcxluced. (R. French and P. Mquist  1987) J. viol. 
and aliquots were electrophoresed on a 12% 61:1457). The AvaI-Sac1 fragment of pB3TP8 was intro- 35 
duced into the XbaI site of pB3BB1 in the same orientation polyacrylamide, 8.3 M urea gel. Marker lanes were prepared 
as the surrounding cDNA to create pB3Sm, and in the except that each contained pM a 
reverse orientation to create pB3SG6R. single &oxynucleotide. and the template was ssDNA pre- 
pB3IC2.3.5.6: In separate constructions, a BamHIlinker pared from phage particles isolated after superinfection of 
(CGCGGATCCGCG, New England Biolabs) was inserted 40 P ~ ~ ~ ~ ~ - ~ ~ ~ ~ ~ ~ ~ ~  E. cozi with phage 
in the AvaI and BglII sites of pB3M1 after filling out the Sequence comparisons were made with the assistance of 
recessed ends with the ~l~~~~ D N A ~ ~ ~ ~ ~ ~ ~ ~ .  -l-he small software from the University of Wisconsin Genetics Com- 
PstI-BamHI fragment of each of these plasmids was ligated puter 
with the large PstI-BamHI fragment of pB3BC1 (French and 
Ahlquist. 1987) to yield intermediate plasmids with the 45 EXAMPLE 3 
cDNA duplications of pB3IC2 and pB3IC3 respectively. 
The small PstI-QaI fragment of each plasmid was then Construction of pB3-SGP and Gene Expression 
exchanged for the small PstI-ClaI fragment of pB3TP8 (to 
substitute a bacteriophage T7 promoter for the E. coli 
 hi^ example describes the construction of a cDNA 
promoter for in ~i t r~ , t raI l~cr ip t i~n)  to yield pB3IC2 and 50 RNA3 derivative which directs the of chloram- 
pB3IC3- In addibonal constructions the large EcoRI- phenicol acetyl transferase ( C N )  activity under the tran- 
Hinc11 fragment P B ~ H S ~  (Rench and Ahlquist. 19g7) scription control of the BMV subgenomicpromoter. wherein 
was ligated with the AvaI-EcORI fragment of P~~~~~ the expression of the subgenomic promoter-CA'J' gene corn- 
or~B31C4'The1arge Bqm-EcoRIfragments of the resultant is from a novel site on the RNA3 molecule, plasrnids were ligated individually with the small BamHI- 55 
EcoRI fragment of pB3BCl to yield pB3IC5 and pB3IC6, The subgenomic promoter-CAT gene complex is cloned 
respectively. as a AvaI-PstI fragment of pB3CA42 (R. French et al. (1986) 
Science 231:1294). After filling out the single-stranded ends 
EXAMPLE 2 with Klenow DNApolymerase. this fragment is cloned into 
~n Vieo Transcription, Protoplast Inoculations and 60 the Xbd site of pB3TW after Similar treatment to create 
RNA Analy sis flush ends; the resultant plasmid in which the orientation of 
the subgenomic promoter-CAT gene complex is the same as This example describes the techniques used to examine in the surrounding cDNA is pB3-SGP. the functionality of BMV wild-type a altered subgenomic 
promoter sequences. 65 RNA transcripts are introduced into barley protoplasts as 
Barley protoplasts were isolated as described (L. Loesch- described in Example 2. CAT gene activity is measured as 
Fries and T. Hall (1980) J. Gen. Virol. 47:323). In vitro described in French et al.. 1986. 
5.633.447 
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IZKAMPLE 4 We claim: 
Construction of pBMVSGP and TWO-Stage Gene 1. Plant tissue comprising a plant cell transformed to 
Expression Controlled by the BMV Subgenomic comprise a DNA segment comprising the nucleotide 
Promoter sequence of a (+) strand plant RNA virus subgenomic core 
This example describes the cons&uction of a recombinant promoter the group of 
DNA molecule containing the subgenomic promoter of tobamoviruses, tobraviruses. bromoviruses, cucumovinrses 
BMY and the bacterial chloramphenicol acetyltransferase and alfalfa mosaic virus, wherein said (+) strand RNA virus 
(CM) gene, such that expression of the CAI' gene is under comprises a consensus sequence selected from the group 
the regulatory control of the st~bgenomic promoter. This consisting of AUCUAUGUU and sequences having a single 
molecule can be used to reduce the BMV subgenomic lo mismatch thereto, a d  further comprising an undeviating 
promoter-dependent CAT gene into plant tissue by domain corresponding to the nucleotide sequence from a 
Illeans lrnown to the art. of the genetically BstX[ site to a BglII site of the cDNA corresponding to the fied plant tissue by treating with BMV genomic RNAs to RNA of FIG. 2, and wherein said activating domain is supply RNA-dependent RNA polymerase activity then turns 
on the expression of the CAT gene under the control of the 1s positioned 5' to said subgenomic core promoter sequence. 
subgenomic promoter. and comprising a plant-expressible structural gene 3' to said 
The Avd-PstI fragment of pB3CA42 (R. French et al. subgenomic core Promoter sequence. said plant-expressible 
(1986) Science 23 1:1294) provides the subgenomic structural gene being heterologous to the native genes of 
promoter-cm gene combination. After repairing single- said plant tissue. and wherein said plant-expressible struc- 
stranded overhangs with Klenow DNA polymerase, this 20 tural gene is expressed 
fragment is inserted at the BamHI site of pGA355+26 (G. 2. The plant tissue of claim 1. wherein said subgenomic 
An et al. (1986) Mol. Gen. Genet. 203:245). Restriction promoter is from home mosaic virus. 
endonuclease digests are performed to choose the product in 3. The plant tissue of claim 2. wherein said subgenomic 
which that the PstI-end is adjacent to the nos promoter, a promoter comprises the subgenomic core promoter 
porn promoter; this recombinant is pBMVSGP. Thus. a 25 sequence. from a B@ site to a SaUI site as in FIG. 2. and 
primary transcript directed by the nos promoter will be a (-) further comprises the BMV activating domain sequence. 
strand with respect to the subgenomic promoter and the CAT from a BstX site to a SalI site as in FIG. 2. wherein said 
coding region. There is no translation initiation site in the activating domain is positioned immediately upstream of 
nos-derived portion of the primary transcript. said core promoter. 
pBMVSGP is introduced into tobacco protoplasts using 30 4. The plant tissue of claim 2, wherein said subgenomic 
the technique of electroporation (M. F r o m  et al. (1985) promoter comprises the core promoter sequence. and further 
proc. Natl. Acad. Sci. 82:5824). Primary (-) strand tran- ~0Inprises an activating domain sequence. from a AvaI site 
scripts will be constitutively synthesized by cellular RNA to a SalI site as in FIG. 2, wherein said activating domain is 
polymerase II. positioned immediately upstram of said core promoter. 
Subgenomic promoter-dependent expression of CP;T is 35 5. The plant tissue of claim 1. wherein said subgenomic 
accomplished by introducing BMY R N A ~  as the source of promoter and said plant-expressible structural gene are not 
RNA-dependent RNA polymerase activity into the geneti- from the same source. 
cally modified tobacco protoplasts, as described by L. 6. The plant tissue of claim 1, wherein said subgenomic 
Loesch-Fries et al. (1985) Virology 143:626. CAT enzy- 'Ore promoter is from 'lfalfa mosaic virus. 
matic activity is measured as described (French et al. 40 
(1986)). 1 : * * * *  

